abstract gray background

Empowering Successful Transitions to Mixed FSP/FSO Model Outsourcing Partnerships

Learn how mixed FSP/FSO outsourcing models improve agility, scalability and operational efficiency in clinical development partnerships.

Download the white paper
PPD FSP empowering-mixed-models white paper cover

As drug developers continue to rely on clinical research organizations (CROs) to effectively navigate clinical trial complexity, the industry looks to CROs to tailor models to their current needs through flexible, efficient and scalable outsourcing solutions. One example is a mixed model outsourcing partnership, which combines elements of full-service outsourcing (FSO) and functional service provider (FSP) models.

Mixed FSP/FSO model outsourcing provides sponsors with additional agility to optimize their clinical development operations, fill capability gaps, address scalability issues, retain control and mitigate risks. To successfully implement a mixed FSP/FSO model, it is vital for sponsors and CROs to understand how to effectively transition to this arrangement.

In this white paper, PPD FSP solutions experts explore:

The strategic foundations necessary for a strong, smooth transition to mixed FSP/FSO models

Best practices for establishing a mixed FSP/FSO model arrangement

How the right CRO partner should be positioned to tailor a solution that integrates seamlessly with new or existing outsourcing partnerships

Optimize clinical outsourcing strategies: Download the white paper